Charles Schwab Investment Management Inc Ocular Therapeutix, Inc Transaction History
Charles Schwab Investment Management Inc
- $601 Billion
- Q3 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,124,103 shares of OCUL stock, worth $12.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,124,103
Previous 1,095,455
2.62%
Holding current value
$12.8 Million
Previous $10.2 Million
29.27%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding OCUL
# of Institutions
237Shares Held
157MCall Options Held
1.24MPut Options Held
791K-
Vr Adviser, LLC New York, NY13.2MShares$150 Million23.37% of portfolio
-
Summer Road LLC West Palm Beach, FL12.6MShares$143 Million98.91% of portfolio
-
Deep Track Capital, LP Greenwich, CT11.9MShares$136 Million4.4% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$131 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.3MShares$117 Million1.64% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $875M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...